A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion
Clinical trial NCT04085341 · COMPLETED
Trial details
- NCT number
- NCT04085341
- Sponsor
- Graybug Vision
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-11
- Primary completion
- 2020-06-05
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.